Robert Stuart to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Robert Stuart has written about Dose-Response Relationship, Drug.
Connection Strength
0.175
-
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia. Br J Haematol. 2015 Mar; 168(6):796-805.
Score: 0.088
-
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. N Engl J Med. 2018 Jun 21; 378(25):2386-2398.
Score: 0.028
-
Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells. Cancer Chemother Pharmacol. 1990; 26(6):397-402.
Score: 0.016
-
Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem cells. J Clin Invest. 1989 Jan; 83(1):100-7.
Score: 0.015
-
Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol. 1985 May; 13(4):295-8.
Score: 0.011
-
Regulation of myelopoiesis in vitro: partial replacement of colony-stimulating factors by tumor-promoting phorbol esters. Blood. 1981 Jun; 57(6):1032-42.
Score: 0.009
-
Tumor-promoting phorbol esters stimulate hematopoietic colony formation in vitro. Science. 1980 Apr 25; 208(4442):402-4.
Score: 0.008